Prescription drug · ANDA
Divalproex Sodium NDC 70518-3055
Divalproex sodium 250 mg/1 · Tablet, Delayed release · Oral · REMEDYREPACK INC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70518-3055-1 | 70518305501 | 100 POUCH in 1 BOX (70518-3055-1) / 1 TABLET, DELAYED RELEASE in 1 POUCH (70518-3055-2)Marketed from Mar 16, 2022 | |
| 70518-3055-3 | 70518305503 | 100 POUCH in 1 BOX (70518-3055-3) / 1 TABLET, DELAYED RELEASE in 1 POUCH (70518-3055-4)Marketed from Aug 9, 2022 | |
| 70518-3055-5 | 70518305505 | 60 TABLET, DELAYED RELEASE in 1 BLISTER PACK (70518-3055-5)Marketed from Jan 4, 2023 | |
| 70518-3055-6 | 70518305506 | 30 TABLET, DELAYED RELEASE in 1 BLISTER PACK (70518-3055-6)Marketed from May 1, 2023 | |
| 70518-3055-7 | 70518305507 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (70518-3055-7)Marketed from Jun 30, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Divalproex Sodium
- Generic name (nonproprietary)
- divalproex sodium
- Active ingredients
- Divalproex sodium — 250 mg/1
- Dosage form
- Tablet, Delayed release
- Route
- Oral
- Labeler
- REMEDYREPACK INC.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090554
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
- Identifiers
- Product ID 70518-3055_571f402c-0293-040b-e063-6294a90ac649SPL ID 571f402c-0293-040b-e063-6294a90ac649SPL set ID 5926c3ff-c995-4789-941c-d38aa7db94dcRxCUI 1099678UNII 644VL95AO6
- Pharmacologic class
- Anti-epileptic Agent; Mood Stabilizer
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470518305501followed by a unit qualifier and the quantityPackage 70518-3055-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Divalproex sodium is an anti-epileptic drug indicated for: Treatment of manic episodes associated with bipolar disorder (1.1) Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures (1.2) Prophylaxis of migraine headaches (1.3) 1.1 Mania Divalproex sodium delayed-release tablets are a valproate and are indicated for the treatment of the manic episodes associated with bipolar disorder. A manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood. Typical symptoms of mania include pressure of speech, motor hyperac…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 090554
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Divalproex Sodium | Divalproex sodium 250 mg/1 | Tablet, Delayed releaseOral | St. Mary's Medical Park Pharmacy | 60760-698 |
| Divalproex Sodium | Divalproex sodium 500 mg/1 | Tablet, Delayed releaseOral | Bryant Ranch Prepack | 71335-2158 |
| Divalproex Sodium | Divalproex sodium 125 mg/1 | Tablet, Delayed releaseOral | A-S Medication Solutions | 50090-7121 |
| Divalproex Sodium | Divalproex sodium 250 mg/1 | Tablet, Delayed releaseOral | Aurobindo Pharma Limited | 65862-402 |
| Divalproex Sodium | Divalproex sodium 500 mg/1 | Tablet, Delayed releaseOral | Aurobindo Pharma Limited | 65862-403 |
| Divalproex Sodium | Divalproex sodium 500 mg/1 | Tablet, Delayed releaseOral | REMEDYREPACK INC. | 70518-2357 |
| Divalproex Sodium | Divalproex sodium 250 mg/1 | Tablet, Delayed releaseOral | American Health Packaging | 68084-776 |
| Divalproex Sodium | Divalproex sodium 500 mg/1 | Tablet, Delayed releaseOral | American Health Packaging | 68084-782 |
| Divalproex Sodium | Divalproex sodium 500 mg/1 | Tablet, Delayed releaseOral | Rising Pharma Holdings, Inc. | 57237-048 |
| Divalproex Sodium | Divalproex sodium 250 mg/1 | Tablet, Delayed releaseOral | Rising Pharma Holdings, Inc. | 57237-047 |
| Divalproex Sodium | Divalproex sodium 125 mg/1 | Tablet, Delayed releaseOral | Rising Pharma Holdings, Inc. | 57237-106 |
| Divalproex Sodium | Divalproex sodium 125 mg/1 | Tablet, Delayed releaseOral | Aurobindo Pharma Limited | 65862-959 |
| Divalproex Sodium | Divalproex sodium 125 mg/1 | Tablet, Delayed releaseOral | REMEDYREPACK INC. | 70518-3683 |